Empowering companies to navigate industry disruption and unlock market leading growth through strategic innovation and competitive resilience

      The life sciences industry is in the midst of a profound transformation, fueled by advancements in technology, sophisticated analytics, and innovative data-driven capabilities. Simultaneously, organizations are grappling with intense pressures related to productivity, pricing strategies, market competition, supply chain resilience, and the ever-present threat of cyber risk. All of this unfolds against a backdrop of accelerating innovation, evolving regulatory landscapes and healthcare ecosystems, and heightened patient expectations.

      We are uniquely positioned to guide pharmaceutical, biotech, MedTech, wholesale/distribution companies through this intricate environment. Whether its modernizing operating models, identifying and unlocking value, from initial transactions to detailed transformations, to harnessing the full potential of AI and technology, or helping to advance, adapt, and activate MedTech innovation.

      Our global life sciences network unites audit, tax, and advisory professionals who collaborate across diverse disciplines. By integrating the experience of scientists, clinicians, financial specialists, data analysts, data scientists, deal advisory and strategy specialists and other advisors, we offer a multifaceted approach to your challenges, delivering coordinated, multidisciplinary processes.


      Spotlight

      As attack surfaces expand and threat actors become ever-more sophisticated, we explore the top cybersecurity considerations, challenges and opportunities facing today’s TMT CISOs.

      As attack surfaces expand and threat actors become ever-more sophisticated, we explore the top cybersecurity considerations, challenges and opportunities facing today’s TMT CISOs.


      Our insights

      A blueprint for creating value through AI-driven transformation

      Beyond the hype: Balancing speed, security and value

      Exploring CEO views on economic growth, technology investments, ESG and workforce

      Our people

      Liz Claydon

      Global Head of Deal Advisory & Global Head of Life Sciences

      KPMG International

      Regional leads

      Kristin Ciriello Pothier

      Principal, US and Americas Region Life Sciences Sector Leader and Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences

      KPMG in the U.S.

      Peter Liddell

      Principal Advisor, Head of Healthcare and Life Sciences, and Global Leader, Operations Centre of Excellence

      KPMG in Singapore

      Jon Haynes

      Client Lead Partner & EMA Head of Life Sciences

      KPMG in the UK